These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. Efficacy and tolerability of fluticasone propionate/salmeterol administered twice daily via hydrofluoroalkane 134a metered-dose inhaler in adolescent and adult patients with persistent asthma: a randomized, double-blind, placebo-controlled, 12-week study. Nathan RA, Rooklin A, Schoaf L, Scott C, Ellsworth A, House K, Dorinsky P. Clin Ther; 2006 Jan; 28(1):73-85. PubMed ID: 16490581 [Abstract] [Full Text] [Related]
14. Salmeterol and fluticasone propionate and survival in chronic obstructive pulmonary disease. Calverley PM, Anderson JA, Celli B, Ferguson GT, Jenkins C, Jones PW, Yates JC, Vestbo J, TORCH investigators. N Engl J Med; 2007 Feb 22; 356(8):775-89. PubMed ID: 17314337 [Abstract] [Full Text] [Related]
15. Fluticasone propionate in asthma: a long term dose comparison study. Verona E, Petrov D, Cserhati E, Hofman J, Geppe N, Medley H, Hughes S. Arch Dis Child; 2003 Jun 22; 88(6):503-9. PubMed ID: 12765916 [Abstract] [Full Text] [Related]
16. Short- and long-term efficacy of fluticasone propionate in subjects with early signs and symptoms of chronic obstructive pulmonary disease. Results of the DIMCA study. van Grunsven P, Schermer T, Akkermans R, Albers M, van den Boom G, van Schayck O, van Herwaarden C, van Weel C. Respir Med; 2003 Dec 22; 97(12):1303-12. PubMed ID: 14682412 [Abstract] [Full Text] [Related]